Business · Business Wire

Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders

The content showcases the Akamai logo and includes a link to their privacy policy. It emphasizes the brand's commitment to secure and reliable performance.

Author

Newsroom Staff

Source

Business Wire

Published

Monday, June 8, 2026

Time

7:00 AM EDT